As Americans become increasingly concerned about the negative health effects of certain foods, manufacturers are introducing a greater variety of healthier products. This move has expanded profit margins throughout the food industries because health-conscious consumers are generally willing to pay more for food that they believe is healthy for them. In particular, large companies that [...]
If the United States continues to outpace the United Kingdom in its recovery, many industries in both countries will have to adjust import and export destinations in addition to reshaping their own product line to remain competitive. Consequently, many downstream industries that deal directly with end-users (i.e. consumers and businesses) will likely face difficulty in [...]
IBISWorld caught up with Nelson Lopez, President and Owner of Infinite Enterprises to find out firsthand what’s going on within the immigration business plan writing services industry. IW: What challenge do you and Infinite Enterprises face right now? NL: The biggest challenge is finding current and comprehensive industry data that will help support the drafting of the [...]
As seen in the RMA Journal Today, Lincoln Logs and Lite-Brites are considered retro, and the days of visiting the local mom-and-pop toy store are a thing of the past. The hobby and toy stores industry has been through some big changes over the past few decades—and even more so in the past five years. [...]
As seen in the RMA Journal By Rick Buczynski and Robert Kennedy Evidence is growing that an increasing number of American households are joining the ranks of the underbanked, shifting away from traditional banking and relying more on alternative financial services (AFS). The “underbanked” are the 24 million households that use a traditional bank for [...]
With huge piles of cash on hand, large-cap pharmaceutical companies, known as Big Pharma, have shown strong interest in acquiring biotech companies with promising drug candidates to help bolster thinning pipelines in the wake of patent expirations. Because of this Patent Cliff, the largest pharmaceutical companies are anticipated to lose about $29.0 billion in revenue [...]
